土耳其选定的慢性病基本药物的价格、可获得性和可负担性

IF 1.7 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Eastern Mediterranean Health Journal Pub Date : 2023-11-30 DOI:10.26719/emhj.23.117

Gökçen Özler, Oğuz Işik

{"title":"土耳其选定的慢性病基本药物的价格、可获得性和可负担性","authors":"Gökçen Özler, Oğuz Işik","doi":"10.26719/emhj.23.117","DOIUrl":null,"url":null,"abstract":"Background: Fair access to essential medicines is a significant parameter in fulfilling the right to basic health. Aim: We investigated the availability, prices and affordability of essential medicines for chronic diseases in Ankara, Türkiye. Methods: We used the procedures outlined in the WHO and Health Action International guidelines for measuring prices, availability, affordability, and price components of medicines. The sample consisted of 334 (14%) of the 2354 pharmacies in Ankara, and 24 essential medicines for cardiovascular diseases, diabetes, chronic respiratory diseases, and palliative care, adopted from the WHO Model List of Essential Medicines (2021). We collected the data in 2021 using a questionnaire administered through face-to-face survey and analysed the data using SPSS version 22. Results: The findings showed that 15 medicines (62.5% of the selected medicines) met the 80% availability target set by WHO, while 9 did not. The original medicines were more readily available than the generic ones. Among the original medicines, furosemide (10.11) and acetylsalicylic acid (9.26) had the highest median price ratios. The generic medicines seemed to be more affordable than original medicines. Glibenclamide, budesonide, gliclazide, and diazepam had low availability and were sold at higher prices than their international reference prices. Conclusion: This research highlights priority areas of action to improve access to affordable medicines for chronic diseases in Ankara, Türkiye.","PeriodicalId":11411,"journal":{"name":"Eastern Mediterranean Health Journal","volume":"14 3","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye\",\"authors\":\"Gökçen Özler, Oğuz Işik\",\"doi\":\"10.26719/emhj.23.117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Fair access to essential medicines is a significant parameter in fulfilling the right to basic health. Aim: We investigated the availability, prices and affordability of essential medicines for chronic diseases in Ankara, Türkiye. Methods: We used the procedures outlined in the WHO and Health Action International guidelines for measuring prices, availability, affordability, and price components of medicines. The sample consisted of 334 (14%) of the 2354 pharmacies in Ankara, and 24 essential medicines for cardiovascular diseases, diabetes, chronic respiratory diseases, and palliative care, adopted from the WHO Model List of Essential Medicines (2021). We collected the data in 2021 using a questionnaire administered through face-to-face survey and analysed the data using SPSS version 22. Results: The findings showed that 15 medicines (62.5% of the selected medicines) met the 80% availability target set by WHO, while 9 did not. The original medicines were more readily available than the generic ones. Among the original medicines, furosemide (10.11) and acetylsalicylic acid (9.26) had the highest median price ratios. The generic medicines seemed to be more affordable than original medicines. Glibenclamide, budesonide, gliclazide, and diazepam had low availability and were sold at higher prices than their international reference prices. Conclusion: This research highlights priority areas of action to improve access to affordable medicines for chronic diseases in Ankara, Türkiye.\",\"PeriodicalId\":11411,\"journal\":{\"name\":\"Eastern Mediterranean Health Journal\",\"volume\":\"14 3\",\"pages\":\"\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eastern Mediterranean Health Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26719/emhj.23.117\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eastern Mediterranean Health Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26719/emhj.23.117","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

摘要

背景：公平获得基本药物是实现基本健康权的一个重要参数。目的：我们调查了土耳其安卡拉慢性病基本药物的可用性、价格和可负担性。调查方法我们采用世界卫生组织和国际健康行动组织指南中规定的程序来衡量药品的价格、可用性、可负担性和价格构成。样本包括安卡拉 2354 家药店中的 334 家（14%），以及 24 种基本药物，分别用于治疗心血管疾病、糖尿病、慢性呼吸系统疾病和姑息治疗，这些药物均采用了世界卫生组织的《基本药物示范目录》（2021 年）。我们通过面对面调查问卷收集了 2021 年的数据，并使用 SPSS 22 版对数据进行了分析。结果显示调查结果显示，15 种药品（占所选药品的 62.5%）达到了世卫组织设定的 80% 的供应目标，9 种未达到。原研药比仿制药更容易获得。在原研药中，呋塞米（10.11）和乙酰水杨酸（9.26）的中位数价格比最高。非专利药似乎比原研药更实惠。格列本脲(Glibenclamide)、布地奈德(Budesonide)、格列齐特(Gliclazide)和地西泮(Diazepam)的供应量较低，售价高于其国际参考价。结论这项研究强调了改善土耳其安卡拉市慢性病患者获得负担得起的药物的优先行动领域。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye

Background: Fair access to essential medicines is a significant parameter in fulfilling the right to basic health. Aim: We investigated the availability, prices and affordability of essential medicines for chronic diseases in Ankara, Türkiye. Methods: We used the procedures outlined in the WHO and Health Action International guidelines for measuring prices, availability, affordability, and price components of medicines. The sample consisted of 334 (14%) of the 2354 pharmacies in Ankara, and 24 essential medicines for cardiovascular diseases, diabetes, chronic respiratory diseases, and palliative care, adopted from the WHO Model List of Essential Medicines (2021). We collected the data in 2021 using a questionnaire administered through face-to-face survey and analysed the data using SPSS version 22. Results: The findings showed that 15 medicines (62.5% of the selected medicines) met the 80% availability target set by WHO, while 9 did not. The original medicines were more readily available than the generic ones. Among the original medicines, furosemide (10.11) and acetylsalicylic acid (9.26) had the highest median price ratios. The generic medicines seemed to be more affordable than original medicines. Glibenclamide, budesonide, gliclazide, and diazepam had low availability and were sold at higher prices than their international reference prices. Conclusion: This research highlights priority areas of action to improve access to affordable medicines for chronic diseases in Ankara, Türkiye.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Eastern Mediterranean Health Journal HEALTH CARE SCIENCES & SERVICESPUBLIC, ENV-PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

CiteScore

3.30

自引率

4.80%

发文量

112

期刊介绍： The Eastern Mediterranean Health Journal, established in 1995, is the flagship health periodical of the World Health Organization Regional Office for the Eastern Mediterranean. The mission of the Journal is to contribute to improving health in the Eastern Mediterranean Region by publishing and publicising quality health research and information with emphasis on public health and the strategic health priorities of the Region. It aims to: further public health knowledge, policy, practice and education; support health policy-makers, researchers and practitioners; and enable health professionals to remain informed of developments in public health. The EMHJ: -publishes original peer-reviewed research and reviews in all areas of public health of relevance to the Eastern Mediterranean Region -encourages, in particular, research related to the regional health priorities, namely: health systems strengthening; emergency preparedness and response; communicable diseases; noncommunicable diseases and mental health; reproductive, maternal, child health and nutrition -provides up-to-date information on public health developments with special reference to the Region. The Journal addresses all members of the health profession, health educational institutes, as well as governmental and nongovernmental organizations in the area of public health within and outside the Region.